Showing posts with label Drug Discovery. Show all posts

Any new medication treating a specific sickness is not discovered and delivered overnight, the normal aggregate time for drug discovery and clinical improvement is around 14 years as when managing any new medication or chemicals the methodology needs to be intensive and guaranteed that two vital perspectives are watching: How protected the medication is and how successful it is at battling an ailment.
Viability
Creating any new medication disclosures will require top to bottom examination of the ailment and additionally the cosmetics of our bodies to figure out which proteins are influenced by the disease or even cause the sickness to happen. The way that these proteins connect with each other can regularly help achieve an understanding of the ailment and how our bodies manage them.
When a disclosure has been made that influences or battles the ailment then refinements will be made to securely expand the Drug Discovery viability in treating the sick. This will mean a harmony between making the medication sufficiently forceful to treat the ailment rapidly additionally verify it stays alright for utilization and doesn't create any symptoms.

Drug Discovery

Tuesday, 2 December 2014
Posted by Unknown
The drug discovery is one of the major players involved in the development of the field of Bioinformatics. Many pharmaceutical companies have internal teams conducting Bioinformatics research. The pharmaceutical industry plays a major role in the world economy. The main purpose is to produce the next major drug. Most drugs are small molecules that are designed to bind, interact, and modulate the activity of specific biological receptors.

Drug discovery - Historical perspective

Drug Discovery began as an extension of chemistry about a century ago. In 1865, Kekule formulate the theory of aromatic organic molecules. Paul Ehlrich applied the selective affinity of dyes for biological tissues to postulate the existence of Chemoreceptors. This led to birth of Chemotherapy - a kind of drug treatment. Pharmacology developed a s a separate stream because of the efforts of Oswald Schmiedeberg at the university of pharmacology between 1871 and 1918. Penicillin was discovered by Alexander Fleming in 1929. The characterization of Carboanhydrase in 1933 was followed by the discovery of Sulphanilamide.

Drug - Definition

A drug is a molecule that interacts with a target biological molecule in the body and trough such interaction triggers a physiological effect.
Chemical compound as Drug

A chemical compound to qualify as a drug should have the following characteristics:
It should beSafeEffectiveStable (both chemically and metabolically)Deliverable (should be absorbed and should reach the site of action)Available (by isolation or by synthesis)Novel (patentable)Areas influencing Drug DiscoveryThere are several approaches to discover new drugs. They vary from Molecular biology to Combinatorial Chemistry.Some of the approaches are as follows:-
Molecular biology has profound influence in Drug Discovery. It applies the concept of genetic information to biochemical and chemical pathways. The protein drugs such as Recombinant proteins and Monoclonal antibodies are called as "Biotech Drugs." Molecular biology can also help us to understand disease processes at molecular or genetic level and to determine optimal molecular targets for drug intervention.

High -Throughput Screening (HTS):

In this method of drug discovery, large numbers of hypothetical targets are incorporated into in-vitro or cell based assays and exposed to large number of compounds representing numerous variations on a few chemical themes.
Pharmacogenetic Technology:
Pharmacogenetics is the study of hereditary basis for differences in a population. Pharmacogenetics makes extensive use of automated tools for protein and gene sequencing. The DNA sequences of human genome are not identical and vary from individual to individual.Pharmacogenetics is hence based on identification of genetic variations (polymorphisms) that alter drug concentrations and responses.
Conclusion
The years of scientific study in the field of pharmacology, molecular biology and biotechnology has led to the process of development of new drugs.Suganya Raphael is an expertise in the field of life science. she is also working in the area of Content development, Social media marketing, blogging and article writing.She has completed her M.Phil in Biotechnology.She is also a wife and mother.

Drug discovery is well-known as the process by which drugs are revealed or designed. A few times back most drugs came to know either by identifying the active ingredient from traditional remedies or either by chance discoveries.
A latest approach explains how disorders, diseases, illness and infections are controlled by ease at the molecular and physiological level and to target specific entities based on this apprehensive. Without being affected by the advances in the technology and understanding of biological systems, drug discovery is still though a time consuming, costly, strenuous, and inefficient procedure with low rate of new disease healing discoveries. 
In 2010, the complete research and development cost of each new molecular entity (NME) was approximately US$1.8 billion. Drug Discovery is finalized by pharmaceutical companies, with highly research assistance from universities.
The conclusive outcome of drug discovery is a patent on the potential drug. The drug requires very expensive Phases clinical trials, and most of them are unsuccessful. Companies at small scale have a critical role, often then selling the rights to large scale companies that have the resources to run the clinical trials.
Discovering drugs that may be a commercial success or a public health success involves a complex interaction between investors; industry, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication.



Welcome to My Blog

- Copyright © Higher Impact Factor Journals -Robotic Notes- Powered by Blogger - Designed by Johanes Djogan -